close
This ad will auto close in 10 seconds
Will retire from Chairmanship of Sanofi India: Vijay Mallya

Will retire from Chairmanship of Sanofi India: Vijay Mallya

Beleaguered liquor baron Vijay Mallya Wednesday announced he will retire as Chairman of Sanofi India and will not seek reelection as a director of the drug maker, nearly a month after he signed a sweetheart deal with Diageo to step down as Chairman of United Spirits Ltd.

Vijay Mallya's board position at Bayer, Sanofi shaky!

Vijay Mallya's board position at Bayer, Sanofi shaky!

With SEBI barring wilful defaulters from board positions at listed companies, the beleaguered Vijay Mallya may be left with no choice but to exit boards of Bayer Cropsciences and Sanofi India in addition to other entities of his UB Group.

Sanofi India Q2 net up 12% at Rs 64.2 crore

Drug firm Sanofi India Tuesday reported a 11.65 percent rise in its standalone net profit at Rs 64.2 crore during second quarter ended June 30, 2015.

Sanofi India Q1 net up 11% at Rs 44 cr

The company, which was previously known as Aventis Pharma, had posted a net profit of Rs 40.1 crore in the same period of 2012.

Sanofi India to double consumer healthcare biz to Rs 1,000 cr

Sanofi India (previously known as Aventis Pharma) Tuesday said it aims to double its consumer healthcare business in the next five years.

Sanofi India net down 6.38% at Rs 51.3 cr in Jul-Sept

The company had posted a net profit of Rs 54.8 crore for the same quarter last fiscal.

Sanofi India Q2 net dips 18.51% at Rs 40.5 cr

The company had posted a net profit of Rs 49.7 crore for the same period previous fiscal, Sanofi India said in a filing to BSE.

Aventis Pharma renamed as Sanofi India

Shareholders of the company had earlier approved the name change at the annual general meeting held on May 3, a company statement said here.